Correlation Between HCW Biologics and BioXcel Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HCW Biologics and BioXcel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and BioXcel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HCW Biologics and BioXcel Therapeutics, you can compare the effects of market volatilities on HCW Biologics and BioXcel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of BioXcel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and BioXcel Therapeutics.

Diversification Opportunities for HCW Biologics and BioXcel Therapeutics

-0.28
  Correlation Coefficient

Very good diversification

The 3 months correlation between HCW and BioXcel is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and BioXcel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioXcel Therapeutics and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with BioXcel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioXcel Therapeutics has no effect on the direction of HCW Biologics i.e., HCW Biologics and BioXcel Therapeutics go up and down completely randomly.

Pair Corralation between HCW Biologics and BioXcel Therapeutics

Given the investment horizon of 90 days HCW Biologics is expected to generate 10.91 times more return on investment than BioXcel Therapeutics. However, HCW Biologics is 10.91 times more volatile than BioXcel Therapeutics. It trades about 0.14 of its potential returns per unit of risk. BioXcel Therapeutics is currently generating about -0.23 per unit of risk. If you would invest  45.00  in HCW Biologics on August 29, 2024 and sell it today you would earn a total of  11.00  from holding HCW Biologics or generate 24.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

HCW Biologics  vs.  BioXcel Therapeutics

 Performance 
       Timeline  
HCW Biologics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in HCW Biologics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, HCW Biologics sustained solid returns over the last few months and may actually be approaching a breakup point.
BioXcel Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioXcel Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

HCW Biologics and BioXcel Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HCW Biologics and BioXcel Therapeutics

The main advantage of trading using opposite HCW Biologics and BioXcel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, BioXcel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioXcel Therapeutics will offset losses from the drop in BioXcel Therapeutics' long position.
The idea behind HCW Biologics and BioXcel Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.